EURETINA 2020 Virtual - Programme Schedule

Programme ScheduleProgramme Overview
EURETINA Sessions Keynotes Symposia Instructional Courses Free Paper Abstracts Poster Abstracts Prize Papers All Days Fri 2nd Sat 3rd Sun 4th Load Favourites

Please note that all times are in Central European Summer Time (CEST)

Programme Filter
timer Loading ... please wait
Fri 02 11:45 - 12:30 CEST
Chairperson(s):
M. Munk SWITZERLAND,  N. Waheed USA, S. Vujosevic ITALY

Channel 2

11.45
S. Vujosevic ITALY
Nomenclature of qualitative and quantitative OCTA parameters

11.53
M. Munk SWITZERLAND
Consensus on OCTA metrics in retinal vascular diseases and standardization of OCTA parameters in clinical trials

12.01
F. Pichi UAE
Consensus on OCTA metrics in inflammatory diseases

12.09
U. Chakravarthy UK
The Unicorn: Expert consensus on OCT A nomenclature in exudative AMD

12.17
Discussion

12.30
End of session

Fri 02 13:45 - 14:30 CEST
Chairperson(s):
B. Bodaghi FRANCE, C. Pavesio UK

Channel 2

13.45
B. Bodaghi FRANCE
Overall role of local therapy and indications in NIU-PS

13.50
C. Pavesio UK
Local and/or systemic strategies: what is the best option for each patient?

13.55
Z. Habot-Wilner ISRAEL
Local therapeutic armamentarium: from A to Z

14.00
U. Pleyer GERMANY
Common complications of local therapies and their management

14.05
Q.D. Nguyen USA
Local Treatment in Development for Uveitis

14.10
M. de Smet SWITZERLAND
Best examples of therapeutic management in current practice

14.15
Discussion

14.30
End of session

 

Fri 02 14:45 - 15:30 CEST
Chairperson(s):
S. Charles USA, T. Rossi ITALY

Channel 2

14.45
T. Rossi ITALY
Welcome and Introduction

14.48
T. Hassan USA
More options for wide-field viewing — back to the future

14.51
P. Stalmans BELGIUM
First reported clinical results from end-stage RP patients implanted with an innovative 3D- neural interface retinal prosthesis

14.54
S. Charles USA
Medium term PFO for inferior RDs, giant breaks (except superior) and macular patch grafts.

14.57
T. Rossi ITALY
Novel instrument for ILM, amniotic and retinal flap manipulation

14.59
D. Steel UK
Sphere of influence and fluctuations in flow during vitrectomy – effect of cutter design

15.02
M. De Smet  SWITZERLAND
Optimizing subretinal delivery via robotics

15.05
S. Rizzo ITALY
A novel multi-function instrument

15.08
Discussion

15.30
End of session

 

Fri 02 15:45 - 16:30 CEST
Chairperson(s):
J. A. Hallak USA, F. G. Holz GERMANY, Maximilian Pfau GERMANY

Channel 2

15.45
N. Hammel USA
ML for predicting conversion to neovascular AMD

15.50
P. Keane UK
Predicting AMD progression using AI

15.55
L. de Sisternes USA
AMD-related biomarker extraction from optical coherence tomography (OCT) and OCT angiography data

16.00
J.A. Hallak  USA
AI in neovascular AMD: prediction of injection requirements

16.05
Joint Discussion – State-of-the-art AI-applications for exudative AMD

16.15
M. Pfau  GERMANY
Beyond RPE-atrophy: novel biomarkers to characterize retinal atrophy progression

16.20
S. Gao  USA
Prediction of disease progression in AMD to improve clinical trial design

16.25
Joint Discussion – Unmet needs and future directions in Geographic Atrophy

16.30
End of session

 

Sat 03 08:45 - 09:30 CEST
Chairperson(s):
A. Laidlaw UK, S. Saidkasimova UK

Channel 2

Panel: Y. Le Mer FRANCE, K. Krepler AUSTRIA, I. Relimpio SPAIN, M. Romano ITALY

08.45
C. Franco Ruedas SPAIN
Presentation 1: Retinal autograph in large refractory macular hole

08.48
Discussion

08.53
C. Iovino ITALY
Presentation 2: Human amniotic membrane plug in a patient with recurrent macular hole and atrophic AMD: what’s the best surgical approach?

08.56
Discussion

09.01
J.B. Ducloyer FRANCE
Presentation 3: Gene therapy: a new complication

09.04
Discussion

09.09
M. Sommer AUSTRIA
Presentation 4: ”Fiat Lux”- A sleeve for vitrectomy light probe modification

09.12
Discussion

09.17
F. Sabatino UK
Presentation 5: ILM flap for the optic disc pit maculopathy

09.20
Discussion

09.25
Announcement of the winner

09.30
End of session

Sat 03 09:45 - 10:30 CEST
Chairperson(s):
A. Grabowska UK, T. Williamson UK

Channel 2

09.45
T. Williamson UK
Introduction and Natural history of RRD

09.49
J. van Meurs THE NETHERLANDS
Pre-operative assessment and management of the macula in RRD

09.53
A. Grabowska UK
Pre-operative management of the macula in PPV for RRD

09.57
D. Yorston UK
Immediate postoperative posturing

10.01
R.J. Hillier UK
Pneumatic retinopexy vs PPV

10.05
T. Williamson UK
Management of the macular displacement and macular folds

10.09
A. Grabowska UK
PVR, retinectomy and the macula

10.13
Discussion

10.30
End of course

Sat 03 10:45 - 11:30 CEST

Channel 2

10.45
Introduction – YOURS committee
C. Dysli SWITZERLAND,
E. de Carvalho UK ,
L. Kuehlewein GERMANY,
R. Mastropasqua ITALY,
Y. Subhi DENMARK,
E. van Dijk THE NETHERLANDS

10.47
C. Iovino ITALY
Photodynamic therapy induced choroidal changes in central serous chorioretinopathy – experience from different countries

10.52
G. Ledesma Gil MEXICO/UK
Don’t throw your fluorescein angiography machine away yet

10.57
M. Bagger DENMARK
The hangman game of uveal melanoma

11.02
R. D’Aloisio ITALY
From smallfield to widefield OCTA in retinal vascular diseases

11.07
T. Nguyen THE NETHERLANDS
Two-year prospective follow-up in patients with CRB1-associated retinal dystrophies: paving the way towards gene therapy

11.12
T. Heeren UK
The end stage of Macular Telangiectasia type 2

11.17
Discussion and announcement of the winner of the Science Slam

11.28
Announcement winner Ophthalmologica lecture

11.30
End of session

Sat 03 13:30 - 13:15 CEST
Chairperson(s):
S. Lesnik-Oberstein THE NETHERLANDS

Channel 2

13.30
We now know how to posture patients after detachment surgery

For: D. Yorston UK
Against: R. Hussain UK

Sat 03 15:30 - 16:15 CEST
Chairperson(s):
F. Bandello ITALY, M. Zarbin USA

Channel 2

15.30
K. Rezaei USA
Zimura trial results

15.38
P. Rosenfeld USA
Apellis trial results

15.46
P. Kaiser USA
Gene therapy for neovascular AMD update

15.54
F. Bandello ITALY
Faricimab update

16.02
Discussion

16.15
End of session

 

Sat 03 16:30 - 17:15 CEST
Chairperson(s):
P. Ferrone USA

Channel 2

16.30
K. A. Rezaei USA
Novel Gene Therapy Approaches for Inherited Retinal Diseases

16.35
T. S. Hassan USA
MD Predictors of Endophthalmitis After Intravitreal Injection: A Multivariable Analysis Based on Injection Protocol and Povidone Iodine Strength

16.40
A. Tufail UK
Anti-VEGF: the future is synthetic?

16.45
P. K. Kaiser USA
New anti-VEGF agents: What’s changed, What’s the same

16.50
F. Boscia ITALY
Small Gauge Surgery of Myopic Foveoschisis

16.55
S. Rizzo ITALY
Retinal Detachment: New Observations to Understand an Old Problem

17.00
Discussion

17.15
End of session

 

Sun 04 09:45 - 10:30 CEST
Chairperson(s):
M. Forlini ITALY, T. Nikolakopoulos GREECE, V. Reppucci USA

Channel 2

09.45
W. Schrader GERMANY
Decisions in severe ocular trauma: when to reconstruct, give up reconstruction, or refer

09.50
TBC
Post-traumatic Endophthalmitis: clinical cases

09.55
TBC
Traumatic Retinal Detachment

09.59
M. Zarbin USA
Surgery for NLP eyes after open globe injury

10.05
K. Sabti KUWAIT
The Use of Endoscopy in Severe Posterior Segment Trauma

10.10
F. Fayyad JORDAN
Severe Trauma In Children

10.15
M. Mura SAUDI ARABIA
Management of post-traumatic complications

10.20
Live Discussion Q&A; Entire Group

10.30
End of session

Sun 04 12:45 - 13:30 CEST
Chairperson(s):
J. Kim USA, D. Ting SINGAPORE

Channel 2

12.45
R. Spaide USA
Choriocapillaris Imaging: Going Deep

12.50
S. Sadda USA
OCT Imaging: What Else for the Future?

12.55
G. Cheung SINGAPORE
Imaging in Myopia: Seeing Far into the Future

13.00
J. Kim  USA
Tele-Ophthalmology: Where Are We Headed?

13.05
L. Lam USA
Augmented Reality: How will it become a reality?

13.10
D. Ting SINGAPORE
AI and Ophthalmology: Sky is the Limit

13.15
Discussion

13.30
End of session

 

EURETINA 2020 Virtual

Frank Holz

Prof. Frank G. Holz, FEBO, FARVO

University Eye Hospital Bonn
EURETINA President

Dear Colleagues,

On behalf of myself and the board of EURETINA, I would like to extend my sincere gratitude to you for supporting EURETINA 2020 Virtual by joining us for our first online meeting on 2 – 4 October. With over 8,000 registrations to the event, we are delighted with the tremendous success of the virtual format.

We hope that you enjoyed the event from the comfort of your home and please be reminded that you can watch all your favourite and missed sessions through EURETINA playback on the virtual platform over the next three months.

I would like to take this opportunity to remind you that through the course of this year, I have initiated together with the board of EURETINA a strategic Roadmap 2025 to outline the priorities of the Society moving forward. You can find a copy of the road map in your virtual briefcase on the virtual platform and website.

The virtual Congress included a virtual Exhibition, as well as virtual Networking Lounges and the usual programme of industry sponsored Satellite Symposia. We are most grateful to our loyal sponsors for their support in this new endeavour and were glad to be able to still have the opportunity to engage directly with them during the annual meeting.

We look forward to seeing you again next year at what we hope will be a live congress. However, this year has taught us that the congress can be successful no matter what the format due to the commitment of its members and supporters.

With very best wishes,

Prof. Frank G. Holz, FEBO, FARVO
President, EURETINA

Registration Information

Virtual Meeting Login

Opens 1200pm CEST Thursday 1 October

Already registered for the Virtual Congress 2020?

Platform for both exhibitors & delegates

Do you have a VAT number? If so, please contact registration@euretina.org for information on how to register. Please also contact us if you are a registered business located outside of the EU.

If you are an EURETINA Member or have submitted an abstract, you may already have an account.

If you do not know the login details for this account, please click on the ‘Forgot password’ link on the registration page and they will be sent to you. Alternatively, contact the Registration Department.

Prices are in Euro & listed without VAT
VAT is charged at 20%
EARLY FEE
5 Aug – 25 Sept
LATE FEE
26 Sept – 4 Oct
EURETINA Member5065
Non – Member95110
Ophthalmic Nurse / Technician*5065

*Documentation such as a work ID or verification letter from your hospital is required and must be uploaded during the registration process for approval.

CME credits will only be awarded to those who attended the live meeting from 2-4 October 2020

Additional Info Categories Groups Cancellations

Keynote Lectures – EURETINA 2020 Virtual

Richard Spaide USA speakerfeature EURETINA Lecture Richard Spaide USA
Marta S. FigueroaKreissig LectureMarta S. FigueroaSPAIN
Stanislao RizzoGisbert Richard Lecture Stanislao RizzoITALY

src

Safety Review Committee (SRC) Report

Post-marketing reports have highlighted the occurrence of intraocular inflammation (IOI) in association with retinal vasculitis and retinal vascular occlusion with brolucizumab, which differs from the common experience with other approved anti-VEGF agents.

A Safety Review Committee (SRC) consisting of clinical trial, imaging, and uveitis experts as well as Data Monitoring Committee members was established by Novartis to independently review these post-marketing cases.

View Report

Sign up to EURETINA


Loading please wait